MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    The Moroccan LRRK2 Registry: Building Resources to Investigate the Penetrance and Phenotype of LRRK2 in North Africans

    Y. Razouqi, M. Megraoui, F. Belahsen, L. Bouguenouch, B. Elmakhzen, H. Ouhabi, J. Aasfara, Y. Zaid, A. Atpu, L. Khalki, M. Rizig (Casablanca, Morocco)

    Objective: The Moroccan LRRK2 Registry aims to establish a comprehensive database integrating clinical data and biosamples to provide valuable insights into the penetrance, phenotype, and…
  • 2025 International Congress

    Quantitative Digitography and Home Diaries for PD Motor State Evaluation

    K. Daley, A. Negi, S. Karjagi, A. Abay, P. Acharyya, P. Schmiedmayer, K. Wilkins, H. Bronte-Stewart (Palo Alto, USA)

    Objective: Assess the feasibility of people with Parkinson’s (PwP) performing 30 seconds of repetitive alternating finger presses using Quantitative Digitography (QDG) technology every 30 minutes…
  • 2025 International Congress

    CSF Mitochondrial DNA Indicates Body Composition and Energy Metabolism in Parkinson’s Disease.

    Y. Mizutani, T. Nakai, Y. Maeda, R. Ohdake, R. Nagao, S. Shima, K. Kawabata, A. Ueda, M. Ito, H. Watanabe (Toyoake, Japan)

    Objective: This study aimed to elucidate the associations between cerebrospinal fluid (CSF) cell-free mitochondrial DNA (cf-mtDNA) levels and body composition, nutritional status, and metabolic biomarkers…
  • 2025 International Congress

    Sleep-wake modulation of subthalamic activity in patients with Parkinson’s disease and conventional or adaptive deep brain stimulation

    L. Caffi, R. Habib, S. Bonvegna, M. Pilleri, G. Pezzoli, C. Palmisano, A. Mazzoni, IU. Isaias (Milan, Italy)

    Objective: To describe the activity of the subthalamic nucleus (STN) during wake and sleep in patients with Parkinson’s disease (PD) with conventional (cDBS) or adaptive…
  • 2025 International Congress

    Characterization of neuronal exosomes purified from plasma of Parkinson’s Disease Chilean patients

    V. Urbina, C. Aguilera, E. Larraechea, D. Sepulveda, R. Vidal (Santiago, Chile)

    Objective: The diagnosis of PD is usually late and has only palliative treatments that seek to slow the progression of motor symptoms. These characteristics make…
  • 2025 International Congress

    Interactions between APOE E4 and idiopathic Parkinson’s disease in age-related hearing loss

    M. Kmiecik, M. Mcintyre, B. Nguyen, A. Guan, M. Holmes, S. Aslibekyan (Sunnyvale, USA)

    Objective: Examine the interaction between APOE E4 and idiopathic Parkinson’s disease (PD) on age-related hearing loss using a validated web-based speech-in-noise assessment. Background: Age is…
  • 2025 International Congress

    Telephone-Based Cognitive Screening for MCI to Dementia in Parkinson’s Disease

    R. Ferrucci, A. de Sandi, F. Verardo, D. Mellace, A. Marfoli, S. Zago, E. Mailland, G. Pravettoni, F. Mameli, F. Ruggiero, E. Zirone, S. Marceglia, A. Priori, F. Cogiamanian, M. Vergari, C. Manzoni, E. Aiello (Milan, Italy)

    Objective: The aim of this study is to evaluate whether telephone-based cognitive screening could be an effective and sustainable alternative to traditional in-person neuropsychological assessment.…
  • 2025 International Congress

    Gender Based Differences in Impulse Control Disorders within Parkinson’s Disease

    N. David, M. Steinberg, L. Higginbotham, R. Tripathi (Atlanta, USA)

    Objective: Analyze associations between gender, dopamine agonists, and levodopa doses in Parkinson’s Disease (PD) patients with Impulse control disorder (ICD). Background: ICDs, which include compulsive…
  • 2025 International Congress

    Long-Term Dementia Risk in the General Parkinson Disease Population

    J. Maple-Grødem, ø. Rustan, D. Bäckström, M. Camacho, C. Counsell, I. Dalen, L. Forsgren, R. Lawson, A. Macleod, C. Williams-Gray, A. Yarnall, OB. Tysnes, G. Alves (Stavanger, Norway)

    Objective: To estimate the long-term risk of developing dementia in the general Parkinson’s disease (PD) population and to assess the influence of age at PD…
  • 2025 International Congress

    Depressive Symptomatology in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia. Descriptive Study of the ESDEPARK Scale.

    P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Maria Villegas-Trujillo, S. Ordoñez-Cure, M. Alejandra Vásquez-Martínez (Zaragoza, Spain)

    Objective: To evaluate the frequency of depression in a group of patients diagnosed with IPDWD, assessed by a new ESDEPARK scale that specifically measures depressive…
  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley